Aprepitant-associated ifosfamide neurotoxicity

J Oncol Pharm Pract. 2010 Jun;16(2):137-8. doi: 10.1177/1078155209346072. Epub 2009 Sep 16.
No abstract available

Publication types

  • Comparative Study
  • Letter
  • Comment

MeSH terms

  • Adult
  • Antidepressive Agents / administration & dosage
  • Antidepressive Agents / adverse effects
  • Antineoplastic Agents, Alkylating / administration & dosage
  • Antineoplastic Agents, Alkylating / adverse effects
  • Aprepitant
  • Case-Control Studies
  • Female
  • Humans
  • Ifosfamide / administration & dosage
  • Ifosfamide / adverse effects*
  • Male
  • Middle Aged
  • Morpholines / administration & dosage
  • Morpholines / adverse effects*
  • Neurotoxicity Syndromes / epidemiology*
  • Neurotoxicity Syndromes / etiology
  • Retrospective Studies
  • Sarcoma / drug therapy
  • Sarcoma / epidemiology

Substances

  • Antidepressive Agents
  • Antineoplastic Agents, Alkylating
  • Morpholines
  • Aprepitant
  • Ifosfamide